# Novo Nordisk (NYSE: NVO) announced a strategic partnership with OpenAI.

*business · news · 2026-04-14 · Finbold*

## Key points

- Novo Nordisk has partnered with OpenAI to integrate AI across all operational areas by 2026.
- Pilot AI programs are already active in Novo Nordisk's research, manufacturing, and commercial teams.
- OpenAI will help upskill Novo Nordisk's workforce to improve AI literacy company-wide.
- Despite the partnership, analysts maintain a cautious 'Hold' consensus on Novo Nordisk stock.
- Novo Nordisk's 2026 outlook predicts a 5% to 13% decline in adjusted sales and operating profit.

**Companies:** Novo Nordisk, OpenAI, Advanced Micro Devices, Broadcom, Oracle
**Countries:** United States, Denmark

[Read the full story on Finbold](https://finbold.com/is-ozempic-maker-stock-a-buy-after-openai-partnership/)

---

Canonical: https://newsio.io/n/e786d744-c085-4543-a41e-af667ad843a1/novo-nordisk-nyse-nvo-announced-a-strategic-partnership-with-openai-the-collabor
Summarized by Newsio from Finbold. https://newsio.io/how-it-works